In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

Zepbound is a prescription drug used to help with weight loss and sleep apnea in certain adults. The starting dosage for weight loss and sleep apnea is 2.5 mg injected once weekly for 4 weeks.

Get the facts on Mounjaro’s dosage. You can also learn how to inject the drug, which form it comes in, and more.

A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...

If tirzepatide remains off the FDA's drug shortage list, ... An injection pen of Zepbound, Eli Lilly's weight-loss drug, is displayed in New York City, on Dec. 11, 2023.

On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been “resolved”.The ...